A prospective randomised trial of isolated pathogens of surgical site infections (SSI)

Konstantinos Alexiou1, Ioannis Drikos1, Maria Terzopoulou1

  • 1Department of Surgery, Sismanoglion General Hospital, Athens, Greece.

Abstract

Insights

Surgical site infections (SSIs) are a significant concern, with common pathogens like E. coli and S. aureus frequently identified. This study analyzed SSI incidence and pathogens in digestive system surgeries, highlighting the need for further research into risk factors.

Area of Science:

  • Surgical infections
  • Clinical microbiology
  • Epidemiology

Background:

  • Surgical wounds are commonly colonized by bacteria, but infections are less frequent.
  • Pathogen distribution in surgical site infections (SSIs) remains consistent, with Staphylococcus aureus, Coagulase-negative Staphylococci, Enterococcus spp., and Escherichia coli being predominant.
  • Increasing rates of SSIs caused by resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans, are a growing concern.

Purpose of the Study:

  • To prospectively evaluate the incidence of surgical site infections (SSIs) in patients undergoing elective digestive system surgery.
  • To identify the main bacterial pathogens responsible for SSIs in this patient cohort.
  • To analyze epidemiological data and patient-related factors associated with SSI development.

Main Methods:

  • A prospective, randomized clinical study conducted from February 2009 to February 2015.
  • Patients undergoing elective upper or lower digestive system surgery received antimicrobial chemoprophylaxis.
  • Detailed monitoring forms captured epidemiological data, surgical information, SSI occurrence (deep and superficial), and postoperative morbidity, with follow-up to 30 days post-discharge.

Main Results:

  • The overall SSI incidence was 4.3% (31/715 patients), with higher rates for lower GI tract surgery (9.3%) compared to upper GI tract surgery (2.2%).
  • The most frequently isolated pathogens were Escherichia coli (20.4%), Enterococcus faecalis (19.5%), Staphylococcus aureus (17.3%), and Bacteroides fragilis (13.4%).
  • All identified SSIs were polymicrobial, and patient factors like obesity, smoking, comorbidities, advanced age, and surgical factors such as complexity and duration were noted as potential independent prognostic factors.

Conclusions:

  • Surgical site infections represent a significant challenge, impacting healthcare services, hospitalization costs, and patient outcomes.
  • Further comprehensive research is required to elucidate predisposing patient characteristics and hospital-related factors for effective SSI prevention strategies.